Related Experiment Video
Updated: Jan 3, 2026
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
Pipetting-based immunoassay for point-of-care testing: Application for detection of the influenza A virus
Ji Yeong Noh1,2, Sun-Woo Yoon2,3, Youngji Kim2,4
1Department of Microbiology, College of Natural Sciences, Chungbuk National University, Cheongju, Republic of Korea.
Insights
A new pipetting-based immunoassay enhances sensitivity for pathogen detection. This method improves upon lateral flow immunoassays (LFIA), offering a more sensitive point-of-care test (POCT) for infectious diseases.
Area of Science:
- Biotechnology
- Immunodiagnostics
- Infectious Disease Detection
Background:
- Point-of-care tests (POCT) are crucial for low-resource settings.
- Lateral flow immunoassays (LFIA) offer speed and ease but lack sensitivity.
- Current LFIA limitations hinder widespread adoption for infectious pathogen analysis.
Purpose of the Study:
- To develop a novel pipetting-based immunoassay for enhanced sensitivity.
- To overcome the sensitivity limitations of traditional LFIA.
- To create a potentially more effective POCT for antigen detection.
Main Methods:
- A magnetic bead-capture system was integrated with a pipette tip for sample purification.
- The immunoassay utilized enzymatic color development or a lateral flow system for quantification.
- The assay was applied to detect influenza A virus nucleoprotein (NP) using HRP-conjugated antibodies.
Main Results:
- The pipetting-based immunoassay demonstrated specific and sensitive detection of influenza A NP.
- Integrating the assay into an LFIA system improved the limit of detection by 100-fold.
- The enhanced LFIA showed significantly greater sensitivity compared to LFIA alone.
Conclusions:
- The novel pipetting-based immunoassay offers a significant improvement in sensitivity.
- This method holds potential for developing sensitive POCT for clinical antigen detection.
- The approach addresses key limitations of existing LFIA technologies.
Abstract:
Point-of-care tests (POCT) for pathogens are considered important for low-resource countries and facilities. Although lateral flow immunoassays (LFIA) have many advantages including speed and ease of use, their sensitivity is limited without specific equipment. Furthermore, their response cannot be enhanced through enzymatic reactions. Owing to these limitations, LFIAs have not yet been generally adopted as the standard protocol for in vitro analysis of infectious pathogens. We aimed to develop a novel pipetting-based immunoassay using a removable magnetic ring-coupled pipette tip. The "magnetic bead-capture antibody-targeted protein complex" was simply purified by pipetting and quantified by enzymatic colour development or using a lateral flow system. This pipetting-based immunoassay was applied to detect the nucleoprotein (NP) of the influenza A virus. Using an HRP-conjugated monoclonal antibody as a probe, the assay allowed for specific and sensitive detection. Furthermore, when this assay was applied exclusively for antigen capture in the lateral flow system, the limit of detection improved 100-fold and displayed greater sensitivity than the lateral flow system alone. Therefore, the pipetting-based immunoassay may be potentially used as a sensitive POCT to clinically detect a target antigen.
